FDA Cites Indian API Maker for Procedural Failures

Drug Industry Daily
A A
The FDA hit Indian API manufacturer Malladi Drugs and Pharmaceuticals with an extensive Form 483 for multiple violations at its facility in Gajulamandyam, Andhra Pradesh.

To View This Article:

Login

Subscribe To Drug Industry Daily